Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04622319 |
|---|---|
| Brief Title: | A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) |
| First Submitted : | November 2, 2020 |
| First Submitted that Met QC Criteria : | November 6, 2020 |
| First Posted : | November 9, 2020 |
| Last Update Submitted that Met QC Criteria : | February 2, 2023 |
| Last Update Posted : | February 3, 2023 |